Acromegaly patients with systemically high GH and IGF-1 levels also have significantly higher incidence of PCa and risk of PCa-related mortality (HR = 1.33 and 1.44, respectively), suggesting that IGF-1 has a positive effect on PCa development and progression, even in humans (58). Here, IGF1 is linked to posterior cortical atrophy.